Medical Device News Magazine

Lumin UV System for Use in Nursing Homes, Ambulatory Care and Primary Care for SARS-CoV-2 N95 Re-Use Is Granted 3B Medical Emergency Use

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

December 4, 2020

Lumin UV system, has received Emergency Use Authorization from the FDA to permit use of the system, on N95 respirators during the COVID-19 pandemic.

Lumin UV system was designed to clean CPAP accessories but is also used as a multi-purpose sanitizer. Today’s announcement by the FDA allows Lumin to be used by healthcare workers employed in nursing homes, long term acute care, ambulatory, primary care, and clinics to allow N95 re-use to stop the spread of COVID-19 and help keep frontline healthcare workers safe.

UVC was first reportedly used for N95 decontamination during the COVID-19 crisis by the University of Nebraska Medical Center. Since then the CDC recognized UVC as a potential means of decontaminating N95 respirators if the proper wavelength and UVC irradiance dose were used. While the FDA has approved other systems for hospital use, the approved systems are complicated, limited to large hospitals, and/or extremely expensive. Lumin is the only N95 decontamination system formally recognized by FDA for killing SARS-CoV-2 that can be purchased for under $300, and with a small enough footprint to be used safely in small offices and clinics, as well as in nursing homes.

Alex Lucio, CEO of 3B Medical, Inc., said, “The COVID-19 global pandemic requires novel approaches and thinking outside the box.  We were starting to get inundated with calls from hospitals and nursing homes asking if Lumin was strong enough to kill SARS-CoV-2. Lumin’s total output in a single 5-minute cycle ranges up to  2,400 mJ/cm2, which studies show is sufficient to kill almost any pathogen, including SARS-CoV-2. A lot of the calls coming into our office are from Fire & Rescue departments, nursing homes, and smaller community hospitals, clinics, and primary care physician offices trying to keep their workers safe.”

He added, “Lumin is likely the only device designed for home use that is powered high enough to repurpose for this use. We are very excited to have our device authorized by FDA for this application”, concluded Lucio.

N95 mask shortages have been widely reported throughout the country, and globally. “Being able to re-use an N95 mask quickly and effortlessly is a game-changer for allowing healthcare workers to remain safe.  Front line healthcare workers are in dire need of an immediate solution to re-use their masks.  Lumin is fast and easy to use and we are glad the device could be re-purposed to meet that need in this crisis,” said Lucio.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”